FDA
approval
· 2022-12-16
FDA Approved: SUBOXONE — Supplemental Application (INDIVIOR INC.)
Summary
FDA approved a supplemental application for Suboxone (buprenorphine/naloxone) submitted by Indivior Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for SUBOXONE (BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE)